ArticleLancet (London, England)2020
Is the HScore useful in COVID-19?
Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Assessment of the HScore as a predictor of disease outcome in patients with COVID-19.BMC pulmonary medicine · 2021Trial
- Secondary Hemophagocytic Lymphohistiocytosis in severe COVID-19 - a retrospective cohort study.Scientific reports · 2025Article
- Hemophagocytic Lymphohistiocytosis Secondary to Acute Human Immunodeficiency Virus and COVID-19.Journal of medical cases · 2024Article
- [Hemophagocytic lymphohistiocytosis and macrophage activation syndrome : A multidisciplinary challenge].Zeitschrift fur Rheumatologie · 2024Review
- COVID-19 Complications in a Newly Diagnosed HIV Patient: A Case of Multiple Herpesvirus Reactivation and HLH Post-ART Initiation.The American journal of case reports · 2023Article
- Severe COVID-19-associated hyperinflammatory syndrome versus classic hemophagocytic lymphohistiocytosis: similarities, differences, and the way forward.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2023Article
- Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19.Frontiers in immunology · 2023Review
- Enigma of COVID-19: is "multisystem inflammatory syndrome in adults" (MIS-A) predictable?BMC infectious diseases · 2022Article
- Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review.Frontiers in immunology · 2022Review
- Case Report: Secondary Hemophagocytic Lymphohistiocytosis (sHLH) andFrontiers in medicine · 2022Article
- Development of a novel score model to predict hyperinflammation in COVID-19 as a forecast of optimal steroid administration timing.Frontiers in medicine · 2022Article
- Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients.Scientific reports · 2021Article
- Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate.Current opinion in rheumatology · 2021Review
- Association of HScore Parameters with Severe COVID-19: A Systematic Review and Meta-Analysis.Iranian journal of medical sciences · 2021Review
- Incidence of Secondary Hemophagocytic Lymphohistiocytosis in Critically-Ill COVID-19 Patients.Cureus · 2021Article
- The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.Infection & chemotherapy · 2021Review
- Systemic and organ-specific immune-related manifestations of COVID-19.Nature reviews. Rheumatology · 2021Review
- Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19.Blood advances · 2020Article
- Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19.Paediatric respiratory reviews · 2020Review
- Bowel ulceration following tocilizumab administration in a COVID-19 patient.BMJ open gastroenterology · 2020Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.